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Introduction
The hepatitis C virus (HCV) is the etiologic agent of acute and chronic hepatitis affecting more than 100 million people worldwide (Uchida, 1994) . Chronic hepatitis is one of the leading causes of liver cirrhosis and hepatocellular carcinoma (Saito et al., 1990) . However, roles and mechanisms, of HCV in the development of this cancer has not been clearly elucidated. HCV, a member of the flavivirus family, has a 9.5-kb positive single-stranded RNA genome, which encodes a polyprotein that is processed into at least 10 different structural and nonstructural proteins (Ray et al., 2001) . Core protein is a structural protein of HCV and is derived from the N-terminus of the polypeptide and has a highly basic N-terminal region and a highly hydrophobic C-terminus. This multifunctional protein has also been implicated in hepatocyte proliferation and transformation. However, its role in cellular proliferation and tumorogenesis has not been well understood.
Phospholipase D (PLD) catalyzes the hydrolysis of phosphatidylcholine (PC), the major membrane phospholipid, to form phosphatidic acid (PA) and choline. PA generally recognized as the signaling product of PLD, functions as an effector in multiple physiological processes (Liscovitch et al., 2000; Steed and Chow, 2001; Kim et al., 2003) . To date, two PLD isoforms, PLD1 and PLD2, have been cloned and characterized (Colley et al., 1997; Hammond et al., 1997) . PLD1 has a low basal activity and is up-regulated by small G proteins (ARF, Rho and Ral), protein kinase C Phospholipase D activity is elevated in hepatitis C virus core protein-transform ed NIH3T3 m ouse fibroblast cells (PKC) , and phosphatidylinositol 4, 5-bisphosphate (PIP2) in vitro. In contrast, PLD2 has a high basal activity, requires PIP2, and is up-regulated by ARF and PKC. It was reported that the ARF-dependent nuclear PLD activity was increased in the S-phase of the regenerating rat liver after partial hepatectomy and also was much higher in AH 7974 cells than in the resting rat liver (Banno et al., 1997) . These results suggested that the nuclear ARF-dependent PLD activity may be associated with cell proliferation. It has been reported that PLD activity is significantly elevated in human cancer tissues (Uchida, 1994; Uchida et al., 1997; Uchida et al., 1999) as well as oncogene-transformed cells (Jiang et al., 1994; Frankel et al., 1999; Fiucci et al., 2000) . Moreover, overexpression of PLD isozymes in fibroblast cells was associated with neoplastic transformation and tumorigenesis (Min et al., 2001) . These results suggest that PLD might play a critical role in regulating cell responses that contribute to mitotic signaling and transformation. Recently, Jung et al. have demonstrated that overexpression of HCV core protein induce transformation of murine fibroblast cells (Jung et al., 2003) . In the present study, we demonstrate that PLD activity is upregulated in HCV core protein-transformed cells.
M aterials and M ethods M aterials
Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum were purchased from Invitrogen (Carlsbad, CA). The antibodies to PKC-α, PKC-δ, and PKC-ξ were purchased from Santa Cruz. PKC isozyme-specific inhibitors (Gö6976, Rottlerin) were from Calbiochem (San Diego, CA). Phospho-p38 and p38 antibodies were from Cell Signaling (Beverly, MA), and PD98059 and SB203580 were from Biomol (Plymouth, PA). Rabbit polyclonal antibody that recognizes both PLD1 and PLD2 was generated as described previously (Lee et al., 2000) . Phosphatidylbutanol (PtdBut) standard was from Avanti Polar Lipid. [9,10- 3 H]myristate were purchased from PerkinElmer Life Sciences. Silica gel 60 A thin layer chromatography plates were from Whatman (Clifton, NJ). Horseradish peroxidase-conjugated anti-mouse IgG and anti-rabbit IgG were from Kirkegaard and Perry Laboratory (Gaithersburg, MD). The enhanced chemiluminescence (ECL) Western blotting detection kit was from Amersham Biosciences (Beverly, MA).
Establishm ent of stable cell lines
Stable NIH 3T3 cells overexpressing HCV core protein were established as described previously (Han et al., 2002) . Construction of pCI-neo-core K (genotype 1b) was made. Stable NIH 3T3 cell lines following transfection with the plasmid including HCV or empty vector were generated and the cells were grown in DMEM supplemented with 10% (v/v) fetal bovine serum and 500 µg/ml G418 under 5% CO2.
Phospholipase D activity assay PLD activity was assessed by measuring the formation of [ 3 H] PtdBut, the product of PLD-mediated transphosphatidylation, in the presence of 1-butanol. Cells were subcultured in 6-well plates at 2×10 5 cells/well and serum-starved in the presence of 1 µCi/ml [ 3 H]myristic acid. After overnight starvation, the cells were washed three times with 5 ml of phosphate-buffered saline (PBS) and pre-equilibrated in serum-free DMEM for 1 h. For the final 10 min of preincubation, 0.3% butan-1-ol was included. At the end of the preincubation, cells were treated with agonists for the indicated times. The extraction and characterization of lipids by thin-layer chromatography were performed as previously described (Min et al., 2002) .
Im m unoprecipitation
The trated cells were lysed with the lysis buffer (20 mM Hepes, pH 7.2, 1% Triton X-100, 1% sodium deoxycholate, 0.2% SDS, 150 m M NaCl, 1 m M Na3VO4, 1 mM NaF, 10% glycerol, 10 µg/ml leupeptin, 10 µg/ml aprotinin, 1 mM phenymethylsulfonyl fluoride, PMSF). The supernatant of cell lysate was collected by centrifugation at 10,000 g for 1 h, and incubated with anti-PLD or anti-PKC antibody complexed to protein A sepharose bead for 4 h at 4 o C with gentle rocking. The immune complexes were collected by centrifugation and washed five times with a buffer (20 mM Tris, pH 7.5, 1 mM EDTA, 1 mM EGTA, 150 mM NaCl, 2 mM Na3VO4, 10% glycerol and 1% Nonidet P-40) and resuspended in sample buffer. The final pellet was loaded onto a polyacrylamide gel for immunoblot analysis.
W estern blotting
Protein samples were analyzed by SDS-polyacrylamide gel electrophoresis on 8% gels and were transferred to a nitrocellulose membrane. The blots were then blocked with 5% non-fat milk and incubated with appropriate primary antibodies followed by incubation with horseradish peroxidase-conjugated secondary antibody. Immunoreactive bands were detected using ECL.
Subcellular fractionation
The cells were harvested and washed twice with ice-cold lysis buffer (20 mM Hepes, pH 7.4, 10% glycerol, 1 mM EDTA, 1 mM EGTA, 1 mM of dithiothreitol, and 1 mM PMSF fluoride and 10 µg/ml leupeptin). The cells were then resuspended in lysis buffer and lysed by ten passages through a 25-gauge needle. Trypan blue staining of the lysate indicate 95% disruption of the cells. The cell lysate was first spun at 500 g for 10 min to remove unbroken cells. The supernatant was then spun at 100,000 g for 1 h at 4 o C to separate the cytosolic and membrane fractions. Membrane fractions were washed twice with the buffer to remove cytosolic proteins.
R esults PLD activity is enhanced in NIH 3T3 cells overexpressing HCV core protein
To understand how PLD activity is regulated in the HCV core protein-transformed cells, the basal PLD activity was compared in both core and vector alone transfected cells. The results shown in Figure 1A , indicated that PLD activity was much higher in the core protein-transformd cells than in the vectortransfected control cells. PMA known to activate both PKC isoforms and PLD, induced further activation of PLD significantly higher in the transformed cells than the control cell. Such increase of PMA-induced PLD activity in the core protein-transformed cells occurs in a time dependent manner ( Figure 1B ). These results demonstrated that PLD activity is up-regulated in the core protein-transformed cells.
PLD1 and PKC are expressed at a sim ilar level in both core protein and vector-transfected cells
To examine whether up-regulation of PLD activity may be due to an enhanced expression of PLD or PKC protein, the expression levels of the both proteins were examined. The result (Figure 2) showed that both the vector and the core protein-transfected cells expressed a similar protein level of PLD1. However, PLD2 was not detected in either cells (data not shown), indicating that the PLD activity shown in these cells may be due mainly to PLD1. Examination of PKC isozyme expression with the isozyme-specific antibodies showed that PKC-α (a conventional PKC), PKC-δ (a novel PKC), and PKC-ξ (atypical PKC) were predominantly expressed. PKC-α was expressed more than other PKC isozymes in these cells. The vector or the core protein-transformed cells showed similar expression level of PKC isozymes. These results suggest that enhanced PLD activity in core proteintransformed cells may be not due to up-regulation of PLD and PKC proteins.
PKC-δ is m ainly involved in PM A -induced PLD activation in HCV core protein-transform ed cells
To identify which isozymes of PKC may be responsible on PMA-stimulated PLD activation in the NIH3T3 cells overexpressing HCV core protein, each PKC isozyme was suppressed by the use of specific inhibitors (Figure 3) . Pretreatment of calcium dependent PKC inhibitor (Gö6976) suppressed PMA-induced PLD activation mildly. In contrast, PMA-induced PLD activation was inhibited dramatically in a dosedependent manner by the pretreatment of cells with Rottlerin, PKC-δ specific inhibitor. These results show that in the core-transformed cells, PKC-δ might be mainly involved in PMA-stimulated PLD activation. PM A induced rapid translocation of PKC-δ from cytosol to m em brane fraction than those of PKC-α in the core-transform ed cells To confirm that PKC-δ is involved in the PMA-induced PLD activation in the HCV core protein-transformed cells, translocation of the PKC isozymes were analyzed by the fractionation of subcellular component of the treated cells and distribution of respective isozymes was identified by western blot. As shown in Figure 4 , treatment of PMA induced a gradual translocation of PKC-α from cytosol to membrane fraction in a time dependent manner in the core proteintransformed cells. But the PKC-δ was rapidly translocated to the membrane fraction post 10 min PMA treatment, whereas a gradual translocation of PKC-δ was observed in the vector-transfected and PMA treated cells suggesting that PKC-δ is mainly responsible for the PMA-stimulated PLD activation in HCV core protein-transformed fibroblasts.
p38 M A PK is involved in PM A -induced PLD activation in HCV core protein-transform ed cells
HCV core protein has been shown to activate both the extracellular signal-regulated kinase (ERK) and the p38 MAPK (Erhardt et al., 2002; Tsutsumi et al., 2003) . A potential participation of these kinases in the PMA-induced PLD activation in HCV core proteintransformed cells was explored. As shown in Figure  5 -A and -B, SB203580, p38 MAPK-specific inhibitor, caused a dose-dependent decrease in PMA-stimulated PLD activity but PD98059, ERK upstream inhibitor, did not. In addition, PMA induced a significant activation of p38 MAPK in both control cell and HCV core protein-transformed cells and pretreatment of SB203580 inhibited PMA-induced p38 activation (Figure 5C ). Interestingly, PMA stimulated p38 MAPK activation far greater extent in the HCV core proteintransformed cells than in control cells. Reprobing the immunoblot with anti-p38 MAPK antibodies showed the equal levels of proteins in each lane. These results suggest that p38 MAPK is involved in PMAinduced PLD upregulation in HCV core protein-transformed cells.
PM A induces activation of p38 M APK via PKC in core-transform ed cells
To determine whether PMA-induced p38 MAPK activation is exerted via PKC-δ, the cells were stimulated with PMA in the presence of Rottlerin, PKC-δ specific inhibitor. As shown in Figure 6 , pretreatment with the Rottlerin suppressed PMA-induced p38 phosphorylation, suggesting that PMA induces activation of p38 via PKC-δ.
D iscussion
In this study, we demonstrated that an overexpression of HCV core protein in NIH3T3 fibroblasts upregulated PLD activity. PLD activity has been found to be markedly elevated in various cancer tissues (Uchida et al., 1997; Uchida et al., 1999; Zhao et al., 2000) , multidrug resistant cancer cells (Fiucci et al., 2000) , and transformed cells (Jiang et al., 1994; Figure 6 . PMA induces activation of p38 MAPK via PKC-δ in core-transformed cells. Serum-starved core-transformed cells were pretreated with 10 µM of Rottlerin (Ro) for 30 min followed by stimulation with PMA for 30 min. Equal amounts of cell lysates (30 µg) were analyzed by SDS-polyacrylamide gel electrophoresis, followed by transfer of proteins to nitrocellulose membrane and immunoblotting with anti-phospho-p38 or anti-p38 antibody. The data shown are representatives of three independent experiments. 3 H] myristic acid, pretreated with the indicated concentrations of SB203580 for 30 min and stimulated with 100 nM PMA for 60 min. The radioactivity incorporated into phosphatidylbutanol was measured as described under "Materials and Methods". Results are the means ± S.D. of three independent experiments. (C) The cells were pretreated with 30 µM of SB203580 (SB) for 30 min followed by stimulation with PMA for 30 min. Equal amounts of cell lysates (30 µg) were analyzed by SDS-polyacrylamide gel electrophoresis, followed by transfer of proteins to nitrocellulose membrane and immunoblotting with anti-phospho-p38 or anti-p38 antibody. The data shown are representatives of three independent experiments. Frankel et al., 1999) . Tumorigenic transformation of fibroblasts was induced by overexpression of PLD isozyme (Min et al., 2001) and transmodulation between PLD and c-Src enhanced cell proliferation (Ahn et al., 2003) . PLD, thus, may be closely associated with in the path of signal transduction leading to cellular proliferation and transformation. Hepatocellular carcinoma (HCC) is one of the most common human cancers in a worldwide basis. Among the several risk factors, chronic infection with either hepatitis C virus is closely related to the development of HCC. HCV core protein has been considered to play important roles during development of HCC by HCV (Koike et al., 2002) . Core protein demonstrated its tumorigenecity by inducing HCC in vivo in transgenic mice (Moriya et al., 1998) . As a multifunctional regulator, core protein is known to deregulate cell cycle checkpoints by modulating transcription of the p21 gene (Jung et al., 2001) . In addition, it can activate the expression of some proto-oncogenes (Ray et al., 1997) . Furthermore, it might modulate mitogenic intracellular signaling pathways as well as apoptotic pathways leading to cell death by interacting several signaling molecules (Shiravastava et al., 1998; Marusawa et al., 1999) . Our earlier report of fibroblast transformation induced by an overexpression of HCV core protein adds to the diversified role of HCV core protein (Jung et al., 2001) . In this study, PMA-induced PLD activity was enhanced in the cells transformed with HCV core protein. Both control and core-transformed cells expressed PLD1 protein, but PLD2 isozyme was not detected. These cells showed no difference in the levels of PLD1 and PKC expressed. Inhibitor of PKC-ξ did not affect PMA-induced PLD activation (data not shown). Moreover, PMA induced rapidly translocation or activation of PKC-δ from cytosol to membrane fraction, whereas PKC-α was gradually translocated into membrane fraction, supporting PKC-δ is significantly involved in PMA-induced PLD activation in core-transformed cells. This indicates that the initial translocation of PKC-δ may be at least partly involved in the PMA-induced PLD activation and that other unidentified mechanism(s) associated with the initial activation of PKC-δ may play an important role in progressive PLD activation.
Protein kinases play a key role in the regulation of cell growth. There is an increasing evidence to suggest that the development of hepatocellular carcinoma might be associated with activation of the Ras/Raf/MAP kinase pathway (Ito et al., 1998) . On the other hand, there are numerous clinical and in vitro studies suggesting a role of the HCV, especially of the HCV core protein, in liver carcinogenesis (Chang et al., 1998; Moriya et al., 1998) . Thus, one may speculate that the HCV core protein plays a key role in the development of human liver disease through activation of the MAP kinase pathway. Indeed, activation of ERK and p38 has been reported for the HCV core protein (Erhardt et al., 2002; Tsutsumi et al., 2003) . However, the influence of the HCV core protein on MAP kinase and the influence of the MAP kinase on disease progression are not fully understood. Since both PLD and HCV core protein have been implicated in the cell proliferation and tumorigenesis, it is possible that PLD and HCV core protein could cross-react at different stages to make a cell pass some of the multi-step required for hepatocarcinogenesis. However, role(s) of PLD signaling in tumorigenesis of core protein-transformed cells requires further study. In the present study, we demonstrated upregulation of PLD activity in the core-transformed cells. These results might provide a clue to understand signaling network for the promotion and/or progression of cancers via PLD and HCV core protein. 
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